MONTPELLIER, France, March 14, 2016 (GLOBE NEWSWIRE) — MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced three new sales of its ROSA™ Brain robotic surgery system in the United States and China.
The Yale Comprehensive Epilepsy Center in New Haven, Connecticut, purchased one system. The facility provides promising treatment options for many adult and pediatric patients. Yale is also internationally recognized for its clinical excellence and innovative research.
The ROSA™ Brain system at the Yale Comprehensive Epilepsy Center will be used for minimally invasive procedures such as stereoelectroencephalography (SEEG), deep brain stimulation, and biopsies. The program will be led by Dennis Spencer, MD, Surgical Director and Harvey and Kate Cushing Professor of Neurosurgery; and Jason Gerrard, MD, PhD, Assistant Professor of Neurosurgery and of Neuroscience and Section Chief, Stereotactic and Functional Neurosurgery.